Neonatal and paediatric intensive care

Hospital Pharmacist

Volumn 10, Issue 2, 2003, Pages 66-71

  Khoo, Ghi Pei ^a   Bolton, Omonefe ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; CHLORAL HYDRATE; CLONIDINE; DEXAMETHASONE; DIPYRIDAMOLE; FENTANYL; IBUPROFEN; INDOMETACIN; KETAMINE; MORPHINE; NALOXONE; NITRIC OXIDE; PARACETAMOL; PROPOFOL; PROSTACYCLIN; SILDENAFIL; TOLAZOLINE; VANCOMYCIN;

ADVERSE DRUG REACTION; ANALGESIA; CHRONIC LUNG DISEASE; DRUG EFFICACY; DRUG INDUSTRY; DRUG OVERDOSE; DRUG TOLERANCE; DRUG USE; HUMAN; INTENSIVE CARE; INTRACRANIAL PRESSURE; LIVER TOXICITY; NEUROLOGIC DISEASE; NEWBORN INTENSIVE CARE; PARENTERAL NUTRITION; PHARMACIST; PRESCRIPTION; PULMONARY HYPERTENSION; REVIEW; RISK MANAGEMENT; SEDATION; WITHDRAWAL SYNDROME;

EID: 0037321329     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Lobas NH, Armitstead JA, Ivey MF. Expanding staff pharmacists' responsibilities to maintain pharmacy services in a neonatal intensive care unit. Am J Hosp Pharm 1991;48:1708-11.
2. Johnson CJ, Lobas NH, Ivey ME Development of a pharmaceutical care system in a neonatal intensive care satellite pharmacy. Am J Hosp Pharm 1993;50:1158-63.
3. Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 1987;79:718-22.
4. Buck ML, Connor JJ, Snipes CJ, Hopper JE. Comprehensive pharmaceutical services for paediatric patients. Am J Hosp Pharm 1993;50:78-84.
5. Dunn JM. Typical babies cared for in a special care baby unit. Hosp Pharm 1996;3:55-8.
6. Stephenson K. Medication used in special care baby units. Hosp Pharm 1996;3:59-61.
7. Canadian Paediatric Society. Enhanced roles for health professionals in newborn care. Paediatrics and Child Health 2000;5:106-9.
8. Hall CM. Pharmacy services to a special care baby unit. Hosp Pharm 1996;3:62-3.
9. Timmins JG, Barr LMA. Paediatric hospital pharmacy practice - Current issues. Hosp Pharm 1999;6:134-8.
10. Conroy S, McIntyre J, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-5.
11. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ 2000;320:79-82.
12. O'Donnell CPF, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002;110:52.
13. American Academy of Pediatrics. Prevention of medication errors in the pediatric inpatient setting. Pediatrics 1998;102: 428-30.
14. Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child 2000;83:492-7.
15. Audit Commission. A spoonful of sugar-medicines management in NHS hospitals. London; 2001.
16. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002;359:1373-78.
17. Glover ML, Sussmane JB. Assessing paediatrics residents' mathematical skills for prescribing medication: A need for improved training. Acad Med 2002;77:1007-10.
18. Armour DJ, Cairns CJ, Costello I, Riley SJ, Davies EG. The economics of a pharmacy-based central intravenous additive service for paediatric patients. Pharmacoeconomics 1996;10:386-94.
19. Bates DW. Using information technology to reduce rates of medication errors in hospitals. BMJ 2000;320:788-91.
20. Mullett CJ, Evans RS, Christenson JC, Dean JM. Development and impact of a computerised paediatric anti-infective decision support program. Pediatrics 2001; 108:75.
21. Department of Health. Discharge of patients from hospital. HC(89)5. London: HM Stationery Office; 1989.
22. Cattell R, Conroy C, Sheikh A. Pharmacist integration into the discharge process: a qualitative and quantitative impact assessment. Int J Pharm Pract 2001;9:59-64.
23. Fielding L, Glynne K, Jones A, Realey C. South Thames Pharmacy Education and Training and University of Brighton. Parenteral therapy. Modules in Applied Therapeutics 2002; (April): 1-79.
24. Pearson G. Handbook of Paediatric Intensive Care. Edinburgh: Elsiever Science Limited; 2002.
25. The Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. Medicines for children. RCPCH Publications Limited on behalf of the RCPCH and the Neonatal and Paediatric Pharmacists Group. London; 1999.
26. Pharmacy Department. Guy's, St Thomas' and Lewisham Hospitals. Paediatric Formulary. 6th ed. London; 2001.
27. Stevens BJ, Franck SL. Assessment and management of pain in neonates. Paediatric Drugs 2001;3:481-558.
28. Arenas-Lopez S, Riphagen S, Davies JG, Tomlin SR, Durward A, Tibby SM. Use of oral clonidine for sedation in paediatric intensive care: correlation of dose, plasma concentration and sedative effects. Neonatal Paediatric Pharmacist Group Conference. Birmingham; 29 Nov, 2002.
29. Wolf A, Ambrose C, Sale S, Howells R, Bevan C, Weir et al. Intravenous clonidine infusion in critically ill children: dose-dependent sedative effects and cardiovascular stability. Br J Anaesth 2000;84: 794-6.
30. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K. A comparison of ibuprofen and indometacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-81.
31. Patel J, Robert I, Azzopardi D, Hamilton P, Edwards AD. Randomised double-blind controlled trial comparing the effects of ibuprofen with indometacin on cerebral haemodynamics in preterm infants with patent ductus arteriosus. Paediatr Res 2000; 47:36-42.
32. Ohlsson A. Back to the drawing board. Pediatr Res 2000;47:4-5.
33. Hariprasad P, Sundarrajan V, Srimathy G, Suthagar B, Ramadevi B. Oral ibuprofen for closure of hemodynamically significant patent ductus arteriosus in premature neonates. Indian Pediatr 2002;39:99-100.
34. Halliday L. Early postnatal dexamethasone and cerebral palsy: Pediatrics 2002;109:1168-9.
35. Durand M, Mendoza ME, Tantivit P, kugelman A, McEvoy C. A randomised trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics 2002;109:262-8.
36. American Academy of Pediatrics, and the Canadian Pediatric Society. Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-8.
37. Romagnoli C, Zezza E, Luciano R, Torrioli G, Tortorolo G. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: A three-year follow-up. Pediatrics 2002;109:1168-9.
38. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002;165:1098-102.
39. Abrahams D, Schulze-Neick I, Magee AG. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000;84:E4.
40. Pawlotsky F, Thomas A, Kergueris MF, Debillon T, Roze JC. Constant rate of infusion of vancomycin in premature neonates: a new dosage schedule. Br J Clin Pharmacol 1998;46:163-7.
41. Borderon JC, Laugier J, Chamboux C, Saliba E, Mathieu A. Continuous infusion of vancomycin during the neonatal period. Pathol Biol (Paris) 1994;42:525-9.
42. Ackerman BH, Vannier AM, Eudy EB. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother 1992;36:1766-69.
43. Naqvi SH, Keenan WJ, Reichley RM, Fortune KP. Vancomycin pharmacokinetics in small, seriously ill infants. Am J Dis Child 1986;140:107-10.